Phase II study of CT-2103 [paclitaxel poliglumex] in patients with metastatic breast cancer
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2007
At a glance
- Drugs Paclitaxel poliglumex (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed.
- 05 Nov 2005 New trial record.